Ambu

Remuneration Information • Nov 8, 2016

Employee shares

Today, Ambu's Board of Directors made a decision to offer employee shares.

The allocation of employee shares is based on the purchase of Ambu shares within the framework of section 7p of the Danish Tax Assessment Act (Ligningsloven) and according to the matching shares principle.

The shares covered by the scheme will be acquired by Danske Bank on 28 and 29 of November 2016 and immediately thereafter transferred to the employees' custody account. The bonus element arises when, after two years of ownership, employees receive one free share for every share purchased, provided that they have not resigned.

Ambu expects to be able to cover the bonus element through its existing portfolio of treasury shares, and no new shares will thus be issued.

The scheme is offered to permanent Ambu A/S employees and employees in subsidiaries directly or indirectly owned by Ambu A/S. To participate in the scheme, employees must be employed on 1 November 2016.

The number of employee shares comprised by the scheme will depend on the number of employees accepting the offer, and to which extent they wish to do so. It is therefore not possible to estimate the number of shares allocated due to the scheme at present, nor to determine the value of the scheme.

Ambu's financial outlook for 2016/17, as announced in company announcement no. 2 2016/17, will not be affected by this issue of employee shares.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

About Ambu

Since 1937, breakthrough ideas have driven Ambu's work to bring efficient healthcare solutions to life within our fields of excellence: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. Millions of patients and healthcare professionals worldwide depend and rely on the functionality and performance of our products. We are dedicated to improving patient safety and advancing single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ and the legendary Blue Sensor™ electrodes to our latest landmark solutions such as the aScope™ – the world's first flexible single-use videoscope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognised medtech companies in the world. Our head office is situated in Ballerup near Copenhagen. Ambu has more than 2,300 employees in Europe, North America, Asia and the Pacific region. You can find more information about Ambu at www.ambu.com.